UiPath price drops — what’s behind today’s move

Traders Union
All News
Financial News
UiPath Slides 5.33% Today to $14.12

Highlights

UiPath CEO Daniel Dines sold 45,000 shares for $675,450 at $15.01 per share on January 26, retaining 27,893,585 shares worth $418.68 million.
The insider sale was disclosed in regulatory filings and does not signify any change in company operations or strategic direction.
PATH trades at $14.12, below its MA-20 and MA-50 but above its MA-200 at $13.43; bearish momentum dominates, with consolidation expected between $14.08 and $14.30.

Insider share sale marks no operational shift amid stable holdings

UiPath recently disclosed an insider transaction involving CEO Daniel Dines, who sold 45,000 shares worth $675,450 on January 26 at an average price of $15.01 per share. Following this sale, Dines retains ownership of 27,893,585 shares valued at approximately $418.68 million. This executive transaction was reported in regulatory filings but does not indicate any change in company operations or strategy.

Anton Kharitonov, expert at Traders Union, sees persistent weakness in PATH. He notes the stock trades below both MA-20 and MA-50, with momentum indicators showing strong bearish bias. Insider selling by the CEO adds to concerns about underlying sentiment, despite not signaling operational changes. Oversold oscillators have yet to drive a rebound, raising the risk of further downside. He cautions, "Until buyers show conviction above $15.94, there is elevated downside risk despite current oversold signals."

Viktoras Karapetjanc, expert at Traders Union, highlights the robust long-term support above the MA-200 as a foundation for further advances. He points to a strong rebound probability with weekly indicators aligning for renewed bullish momentum. While insider selling often raises questions, he interprets stable, large CEO ownership as a vote of confidence. The market structure favors upward moves should price overcome $15.94. He states, "Bullish structure remains intact and I expect further growth as long as price stays above the $13.43 long-term support."

Jainam Mehta, market strategist, takes a scenario-based approach. He notes pronounced intraday volatility and divergence between daily oversold technicals and longer-term bullish signals. The sideways consolidation band between $14.08 and $14.30 offers tactical range-trading potential. Mehta adds, "Contrarian entries may be considered if downward momentum fades and price holds above the long-term moving average."

Oversold signals intensify as bearish momentum and volatility rise

Momentum indicators for PATH are dominantly bearish, with the daily MACD signaling a sell and ADX at 16.98 suggesting a lack of clear trend strength. Oscillators reveal increasing oversold conditions: the RSI stands at 44.24 (mildly bearish), Stoch RSI at 27.16 (neutral but near oversold), and CCI at -66.57 (negative bias); BBP further confirms a strong oversold reading. The daily price is down 5.33%, opening with a minimal gap and trading near the intraday low, indicating heightened volatility and pronounced downward pressure after the open. Divergence is evident, as oversold signals have not yet prompted a meaningful recovery, and intraday momentum confirms continued downside pressure. The nearest resistance is set at the Ichimoku Kijun level of $15.94.

Last time, analysts noted that UiPath Inc. is trading below its short- and medium-term moving averages, with technical momentum indicators—including MACD and ADX—signaling a weak trend and strong seller dominance, while longer-term support persists above the 200-day average. Despite oversold conditions and persistent downside pressure, near-term price action is expected to remain range-bound between support near $14.00 and resistance at $14.90, with a potential shift if either boundary is breached.

Source of Data: PATH Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.